Changes in ovarian function in premenopausal women with breast cancer undergoing adjuvant TC (docetaxel and cyclophosphamide) chemotherapy during a brief period of amenorrhea around the last chemotherapy cycle

PURPOSE: Docetaxel, a chemotherapeutic agent, induces high rates of transient chemotherapy-induced amenorrhea (CIA) when used as adjuvant chemotherapy for premenopausal women with breast cancer. Clinical laboratory data to assess the hormonal environment implicated in inducing transient CIA was asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshimura, Keiko, Furuya, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112198/
https://www.ncbi.nlm.nih.gov/pubmed/25077063
http://dx.doi.org/10.1186/2193-1801-3-352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112198/
https://www.ncbi.nlm.nih.gov/pubmed/25077063
http://dx.doi.org/10.1186/2193-1801-3-352

Ejemplares similares